Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone with Carboplatin and Gemcitabine in NSCLC
NCT00247416Phase 2Completed
- Start
- Aug 2005
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexamethasone in non-small cell lung cancer (NSCLC) (2 arms). Primary endpoint: Percentage of Participants With Reduction in Grade 3/4 Neutropenia. Started Aug 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00247416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247416.